000			01245nam a22001937a 4500
999			_c3832 _d3832
005			20221114135201.0
008			221021b ||||| |||| 00| 0 eng d
020			_a9781509868087
082			_a338.7681761 _bCAR
100			_aCarreyrou, John _99054
245			_aBad blood: _bsecrets and lies in a silicon valley startup
260			_bPicador  _aLondon _c2018
300			_axii, 339 p.
365			_aINR _b650.00
520			_aIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley
650			_aHematologic equipment industry _99783
650			_aSecurities fraud _95807
942			_2ddc _cBK